SACRAMENTO – As the first and only state contracting for its own affordable insulin, Governor Gavin Newsom today announced that CalRx® biosimilar insulin glargine pens will be available to consumers in California beginning January 1, 2026. This launch marks a significant step in the state’s ongoing effort to lower prescription drug prices and improve medication access … Governor Newsom announces affordable CalRx® insulin, $11 a pen, will soon be available for purchase Read More » Th...
